Immunome, Inc.IMNMNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+600.5%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+600.5%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
343.8x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$1.72M-86.6%
2024$12.84M+371.3%
2023$2.72M+54380.0%
2022$5000.00-99.0%
2021$493000.00+108.8%
2020$-5.58M-5708.3%
2019$-96000.00+5.9%
2018$-102000.00-